NCT05682209View on ClinicalTrials.gov

The Effect of Octreotide on Wound Drainage After Mastectomy

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 18, 2020

Primary Completion Date

November 15, 2021

Study Completion Date

December 2, 2021

Conditions
Seroma Following Procedure
Interventions
DRUG

Octreotide Injection

100µg of octreotide intravenously 8-hourly for 5 days from the first post-operative day

OTHER

Sterile water

1ml of sterile water intravenously 8-hourly for 5 days from the first post-operative day

Trial Locations (1)

+234

University College Hospital, Ibadan

All Listed Sponsors
lead

Ikechukwu Bartholomew Ulasi

OTHER

NCT05682209 - The Effect of Octreotide on Wound Drainage After Mastectomy | Biotech Hunter | Biotech Hunter